Acute Pericarditis: Aetiologic Diagnosis and Practical Aspect of the Management

被引:4
|
作者
Bouriche, Fatima [1 ]
Toro, Alexandre [1 ]
Negre, Valerie [1 ]
Yvorra, Serge [1 ]
机构
[1] Ctr Hosp Martigues, Martigues, France
关键词
D O I
10.1016/j.cpcardiol.2020.100769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pericarditis is an uncommon pathology that represents 0.1% of patients hospitalized for chest pain with a wide etiological spectrum and whose cause is uncommonly highlighted. In order to determine the incidence of specific acute microbiological or autoimmune pericarditis and identify subsets of patients with a higher incidence of specific etiologies; and analyze the conformity of the management of acute pericarditis according to the recommendations, a retrospective inclusion of all patients admitted to our hospital from January 2010 to December 2018 with the diagnosis of acute pericarditis was conducted. Data concerning clinical, paraclinical and treatment items were collected. Ninety-nine patients were included. Specific etiologic exams were completely conducted in 63.6% of the patients. There was no link between the decision to conduct etiology exams and the age, gender, a history of acute pericarditis or relapse. There was a trend between an elevated CRP and the realization of the kit. There was a statistically significant link between the achievement of etiologic exams and the presence of severity criteria or the presence of a pericardial effusion. An etiology was found in 52.4%, more frequently microbiological (viral and Mycoplasma pneumoniae). Approximately 85.9% of all patients were hospitalized. Treatment was in accordance with the recommendations in 76.8%. Despite the percentage of microbiological etiologies found, it does not impact the therapeutic strategy. The criteria for hospitalization must be better suited since half of those hospitalized after the european society of cardiology (ESC) 2015 recommendations had no need to be. However, monitoring after discharge is not clearly defined by learned societies.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] CONSTRICTIVE PERICARDITIS - MODERN VIEW OF DIAGNOSIS AND MANAGEMENT
    HANCOCK, EW
    JOURNAL OF CARDIOVASCULAR MEDICINE, 1980, 5 (04): : 367 - &
  • [32] DIAGNOSIS AND MANAGEMENT OF PURULENT PERICARDITIS - EXPERIENCE WITH PERICARDIECTOMY
    MAJID, AA
    OMAR, A
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (03): : 413 - 417
  • [33] Diagnosis and Management of Tuberculous Pericarditis: What Is New?
    Godsent Isiguzo
    Elsa Du Bruyn
    Patrick Howlett
    Mpiko Ntsekhe
    Current Cardiology Reports, 2020, 22
  • [34] Constrictive pericarditis: diagnosis, management and clinical outcomes
    Welch, Terrence D.
    HEART, 2018, 104 (09) : 725 - 731
  • [35] Diagnosis and Management of Tuberculous Pericarditis: What Is New?
    Isiguzo, Godsent
    Du Bruyn, Elsa
    Howlett, Patrick
    Ntsekhe, Mpiko
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (01)
  • [36] Multimodality approach to the diagnosis and management of constrictive pericarditis
    Ansari-Gilani, Kianoush
    Gilkeson, Robert C.
    Kikano, Elias G.
    Hoit, Brian D.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2020, 37 (04): : 632 - 636
  • [37] Regarding the Practical Guide Updating for the Treatment of Acute Pericarditis in Cienfuegos
    Cabrera Nunez, Rene Mick
    FINLAY, 2019, 9 (04): : 240 - 242
  • [38] SURGERY IN ACUTE AND CHRONIC PERICARDITIS - PATHOPHYSIOLOGY AND MANAGEMENT
    KLUGE, T
    HALL, KV
    SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1976, 10 (01): : 21 - 30
  • [39] Management of Hospitalized Patients With Acute and Recurrent Pericarditis
    Schwier, Nicholas C.
    US PHARMACIST, 2022, 47 (02) : HS9 - HS12
  • [40] MANAGEMENT OF ACUTE PERICARDITIS SUSPENSION AT FAMILY MEDICINE
    Bushulaybi, Naimah Abdullatif
    AlAbdulwahab, Norah Khalid
    Almutawaa, Jihan Mohammed
    Aldakhil, Hala Abdulrahman
    Aimulhim, Fai Abdulmohsin
    Alumair, Nesreen Abdullah
    Alghamdi, Arwa Yahya
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 9256 - 9262